$31.95 0.05 (+0.16%)
2/13/2012 2:31 PM

Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Featured Broker Partners


Advertisement